BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7028531)

  • 1. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW; Holden E
    J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
    Ebbutt AF; Elsdon-Dew RW
    J Int Med Res; 1979; 7(6):524-7. PubMed ID: 520655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
    Ebbut AF; Elsdon-Dew RW; Murphy JE
    J Int Med Res; 1978; 6(6):494-8. PubMed ID: 720740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
    Levenstein JH
    S Afr Med J; 1981 Jun; 59(25):893-9. PubMed ID: 7015537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1979 Jan; 55(4):114. PubMed ID: 424946
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
    Forrest WA
    J Int Med Res; 1981; 9(6):490-4. PubMed ID: 7033014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract]   [Full Text] [Related]  

  • 11. An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
    Forrest WA
    J Int Med Res; 1980; 8(2):127-31. PubMed ID: 6102939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
    Ballantyne D; Ballantyne FC; McMurdo
    Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
    Goble AJ
    Med J Aust; 1975 Jan; 1(SP2):14-7. PubMed ID: 1124020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 17. Potassium supplements.
    Waal-Manning HJ
    N Z Med J; 1982 May; 95(707):326. PubMed ID: 6954394
    [No Abstract]   [Full Text] [Related]  

  • 18. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA
    Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.